R Asselta
Overview
Explore the profile of R Asselta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rimoldi V, Paraboschi E, Menegatti M, Peyvandi F, Salomon O, Duga S, et al.
Haemophilia
. 2017 Nov;
24(2):e50-e55.
PMID: 29178608
No abstract available.
2.
Asselta R, Robusto M, Braidotti P, Peyvandi F, Nastasio S, DAntiga L, et al.
J Thromb Haemost
. 2015 Jun;
13(8):1459-67.
PMID: 26039544
Background: Quantitative fibrinogen deficiencies (hypofibrinogenemia and afibrinogenemia) are rare congenital disorders characterized by low/unmeasurable plasma fibrinogen antigen levels. Their genetic basis is invariably represented by mutations within the fibrinogen genes...
3.
Biguzzi E, Franchi F, Acaia B, Ossola W, Nava U, Paraboschi E, et al.
Haemophilia
. 2014 Oct;
20(6):e377-83.
PMID: 25333208
Postpartum haemorrhage (PPH) is a leading cause of maternal mortality, particularly in the developing countries, and of severe maternal morbidity worldwide. To investigate the impact of genetic influences on postpartum...
4.
Srulijes K, Hauser A, Guella I, Asselta R, Brockmann K, Schulte C, et al.
Eur J Neurol
. 2013 Mar;
20(4):e61-2.
PMID: 23490118
No abstract available.
5.
6.
Paraboschi E, Kayiran S, Ozbek N, Gurakan B, Peyvandi F, Guella I, et al.
Haemophilia
. 2011 Jul;
18(2):205-10.
PMID: 21777354
Factor V (FV) deficiency is a rare coagulation disorder, characterized by a bleeding phenotype varying from mild to severe. To date, 115 mutations have been described along the gene encoding...
7.
Mannucci P, Asselta R, Duga S, Guella I, Spreafico M, Lotta L, et al.
J Thromb Haemost
. 2010 Jul;
8(10):2116-21.
PMID: 20626623
Unlabelled: Aims: Gain-of-function variants of genes encoding coagulation factor V (F5 G1691A) and prothrombin (F2 G20210A) cause hypercoagulability and are established risk factors for venous thrombosis. A meta-analysis of 66,155...
8.
Asselta R, Spena S, Duga S, Tenchini M
Cardiovasc Hematol Agents Med Chem
. 2007 Apr;
5(2):163-73.
PMID: 17430139
Fibrinogen is a complex glycoprotein involved in the final step of the coagulation cascade as the precursor of fibrin monomers that participate in the formation of the haemostatic plug. Three...
9.
Asselta R, Duga S, Tenchini M
J Thromb Haemost
. 2006 Sep;
4(10):2115-29.
PMID: 16999847
Hereditary fibrinogen disorders include type I deficiencies (afibrinogenemia and hypofibrinogenemia, i.e. quantitative defects), with low or unmeasurable levels of immunoreactive protein; and type II deficiencies (dysfibrinogenemia and hypodysfibrinogenemia, i.e. qualitative...
10.
Peyvandi F, Jayandharan G, Chandy M, Srivastava A, Nakaya S, Johnson M, et al.
Haemophilia
. 2006 May;
12 Suppl 3:82-9.
PMID: 16684001
Inherited deficiencies of plasma proteins involved in blood coagulation generally lead to lifelong bleeding disorders, whose severity is inversely proportional to the degree of factor deficiency. Haemophilia A and B,...